Petros Pharmaceuticals, Inc. Class of Warrant or Right, Outstanding
Petros Pharmaceuticals, Inc. (PTPI) had Class of Warrant or Right, Outstanding of 2.63 billion shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-13
- 2026-06-30: Class of Warrant or Right, Outstanding 2.63B shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 140.79M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 140.82M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 140.84M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 2.63B shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 140.79M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 140.82M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 140.84M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 140.84M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 5.94M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 324.27K shares 10-K · filed 2026-04-15 | 8.11M shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 8.19M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 8.19M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 8.20M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 328.15K shares 10-K · filed 2026-04-15 | 8.20M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 8.20M shares 10-Q · filed 2023-11-15 | |
| 2023-06-30 | 1.00M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 1.00M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 1.00M shares 10-K · filed 2025-03-31 | |
| 2022-09-30 | 10.04M shares 10-Q/A · filed 2022-11-15 | |
| 2022-06-30 | 10.04M shares 10-Q · filed 2022-08-12 | |
| 2022-03-31 | 10.04M shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 1.00M shares 10-K · filed 2024-04-01 | 10.04M shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 4.41M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 4.41M shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 4.41M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 441.04K shares 10-K · filed 2023-03-31 | 4.41M shares 10-Q · filed 2021-05-14 |
| 2019-12-31 | 4.41M shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |